CLOROX|DE ($CLX) posted quarterly earnings results for Q3 2026 on Thursday, April 30th. The company reported earnings of $1.64 per share, beating estimates of $1.57 by $0.07. The company also reported revenue of $1,670,000,000, missing estimates of $1,683,274,160 by $-13,274,160.
Stock price change since market close: -2.99%
You can see Quiver Quantitative's $CLX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CLOROX|DE Insider Trading Activity
CLOROX|DE insiders have traded $CLX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CLX stock by insiders over the last 6 months:
- PIERRE R BREBER purchased 4,000 shares for an estimated $416,516
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
CLOROX|DE Hedge Fund Activity
We have seen 470 institutional investors add shares of CLOROX|DE stock to their portfolio, and 569 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,184,556 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $321,098,781
- STIFEL FINANCIAL CORP removed 2,378,720 shares (-78.3%) from their portfolio in Q4 2025, for an estimated $239,846,337
- CITADEL ADVISORS LLC added 1,403,060 shares (+5350.3%) to their portfolio in Q4 2025, for an estimated $141,470,539
- MORGAN STANLEY removed 902,664 shares (-28.2%) from their portfolio in Q4 2025, for an estimated $91,015,611
- INVESCO LTD. added 884,751 shares (+22.1%) to their portfolio in Q4 2025, for an estimated $89,209,443
- TWO SIGMA ADVISERS, LP removed 778,100 shares (-38.2%) from their portfolio in Q4 2025, for an estimated $78,455,823
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 739,005 shares (+6907.9%) to their portfolio in Q4 2025, for an estimated $74,513,874
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
CLOROX|DE Congressional Stock Trading
Members of Congress have traded $CLX stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CLX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 12/19 and 1 sale worth up to $15,000 on 11/12.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
CLOROX|DE Price Targets
Multiple analysts have issued price targets for $CLX recently. We have seen 11 analysts offer price targets for $CLX in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- Dara Mohsenian from Morgan Stanley set a target price of $110.0 on 04/23/2026
- Kaumil Gajrawala from Jefferies set a target price of $139.0 on 04/21/2026
- Andrea Teixeira from JP Morgan set a target price of $99.0 on 04/17/2026
- Lauren Lieberman from Barclays set a target price of $102.0 on 04/15/2026
- Filippo Falorni from Citigroup set a target price of $110.0 on 04/15/2026
- Chris Carey from Wells Fargo set a target price of $110.0 on 04/08/2026
- Peter Grom from UBS set a target price of $110.0 on 04/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
